Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-07-02-2002, Volume 26, Issue 7

The author discusses the Japanese cabinet's approval of a measure that lifts manufacturing restrictions on domestic pharmaceutical companies.

Related Content:

Bio/Pharma BusinessOutsourcingManufacturingContract Manufacturing, GeneralPharmaceutical Technology-07-02-2002
Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
Capsida Previews Its Oral and Poster Presentations for ASGCT 2025
CN Bio Forms Strategic Partnership with Pharmaron to Develop OOC Technologies